Insider · CIK 0001273858
Dennis N Berman
Files at IKT (Inhibikase Therapeutics, Inc.). First filing -, latest -.
Dennis N Berman files SEC Form 4 as director at IKT (Inhibikase Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dennis N Berman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +155,000 | $0.00 | $0 | 155,000 | Jun 30, 2026 |
| Jun 30, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +108,176 | $0.00 | $0 | 108,176 | Jul 2, 2025 |
| Feb 14, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +39,620 | $0.00 | $0 | 39,620 | Feb 19, 2025 |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Molino Ventures, LLC | -21,854 | $0.00 | $0 | 0 | Jan 22, 2025 |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivativeindirect: By Molino Ventures, LLC | +21,854 | $0.00 | $0 | 21,854 | Jan 22, 2025 |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,138 | $0.00 | $0 | 0 | Jan 22, 2025 |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,138 | $0.00 | $0 | 1,138 | Jan 22, 2025 |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Molino Ventures, LLC | -3,780 | $0.00 | $0 | 0 | Jan 22, 2025 |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivativeindirect: By Molino Ventures, LLC | +3,780 | $0.00 | $0 | 3,780 | Jan 22, 2025 |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Molino Ventures, LLC | -6,667 | $0.00 | $0 | 0 | Jan 22, 2025 |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivativeindirect: By Molino Ventures, LLC | +6,667 | $0.00 | $0 | 6,667 | Jan 22, 2025 |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Molino Ventures, LLC | -6,667 | $0.00 | $0 | 0 | Jan 22, 2025 |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivativeindirect: By Molino Ventures, LLC | +6,667 | $0.00 | $0 | 6,667 | Jan 22, 2025 |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Molino Ventures, LLC | -30,000 | $0.00 | $0 | 0 | Jan 22, 2025 |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivativeindirect: By Molino Ventures, LLC | +30,000 | $0.00 | $0 | 30,000 | Jan 22, 2025 |
| Jan 3, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +344,452 | $0.00 | $0 | 344,452 | Jan 7, 2025 |
| Jan 3, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +172,191 | $0.00 | $0 | 172,191 | Jan 7, 2025 |
| Jan 3, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +316,647 | $0.00 | $0 | 316,647 | Jan 7, 2025 |
Questions about Dennis N Berman
Answered from the filings on this page, as of the latest one.
Is Dennis N Berman buying or selling?
Dennis N Berman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dennis N Berman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dennis N Berman has 0.
Where does Dennis N Berman file Form 4?
Dennis N Berman has filed Form 4 at IKT (Inhibikase Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.